In an article published on the Health Affairs Blog, NPC and the Analysis Group conducted market research and found that although payers are thinking about how to cover gene therapies, more work is needed to fully address seven important coverage challenges.

The U.S. Food and Drug Administration took significant steps to modernize how health care information is communicated. The two final guidance documents address communications questions as well as many concerns raised by NPC through our longstanding research in this area and in public testimony and comments.

Join NPC and health care stakeholders at MedCity CONVERGE in Philadelphia, Pennsylvania, on July 11-12 for a two-day summit on oncology innovation. NPC Chief Science Officer and Executive Vice President Robert W. Dubois, MD, PhD, will address “Promising Drugs, Pricing and Access” in a panel discussion on Thursday, July 12, from 10:30 a.m.-11:45 a.m.